# Regeneron Pharmaceuticals, Inc.: Form DEF 14A, filed Apr 21, 2022

- Company: [Regeneron Pharmaceuticals, Inc.](/companies/regn.md) (CIK 872589)
- Form: DEF 14A
- Filed: 2022-04-21
- Accepted by EDGAR: Apr 21, 2022, 16:09 ET
- Period: 2022-06-10
- Accession: 0000930413-22-000787
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/872589/000093041322000787/c102797_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/872589/000093041322000787/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/872589/000093041322000787/c102797_def14a.htm

Filed Apr 21, 2022.
Source: SEC EDGAR, the filing index for accession 0000930413-22-000787. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.
